Elien B. Uitvlugt - Concepedia

Author

Elien B. Uitvlugt

OLVG ORCID

Also Known As

Elien B Uitvlugt, Elien B. Uitvlugt, Elien Uitvlugt

Publications

450

Citations

H-Index

Concepts

All Affiliations

OLVG Radboud University Nijmegen Sint Maartenskliniek Radboud University Medical Center University Medical Center Groningen

About

Elien B. Uitvlugt is an author at OLVG specializing in public health, primary care, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	56
2	Public Health	2	2	56
3	Health Informatics	2	2	56
4	Nursing	1	1	32
5	Family Medicine	1	1	32

Elien B. Uitvlugt

Publications

211

Citations

H-Index

Page 1

	Year	Citations
Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors Elien B. Uitvlugt, Marjo J. A. Janssen, C. E. H. Siegert, Frontiers in Pharmacology	2021	71
Completeness of medication-related information in discharge letters and post-discharge general practitioner overviews Elien B. Uitvlugt, C. E. H. Siegert, Marjo J. A. Janssen, International Journal of Clinical Pharmacy NursingFamily MedicinePrimary CareDrug Information SystemPatient Safety	2015	32
Preventability of unplanned readmissions within 30 days of discharge. A cross-sectional, single-center study Albertine M. B. van der Does, E. Kneepkens, Elien B. Uitvlugt, PLoS ONE	2020	27
Validity of a nationwide medication record system in the Netherlands Elien B. Uitvlugt, Bart J. F. van den Bemt, Wai Lung Chung, International Journal of Clinical Pharmacy Primary CareMedical RecordsHealth PolicyClinical DatabaseDrug Information System	2019	24
Clinical characteristics and risk factors of preventable hospital readmissions within 30 days Elsemieke A.I.M. Meurs, C. E. H. Siegert, Elien B. Uitvlugt, Scientific Reports	2021	17
Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non–Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy Marjon V. Verschueren, Bas Peters, Lourens T. Bloem, Clinical Lung Cancer	2023	15
The effect of a transitional pharmaceutical care program on the occurrence of ADEs after discharge from hospital in patients with polypharmacy Elien B. Uitvlugt, Selma En‐nasery‐de Heer, Bart J. F. van den Bemt, Research in Social and Administrative Pharmacy	2021	13
Implementation of a pharmacist‐led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH) Selma En‐nasery‐de Heer, Elien B. Uitvlugt, Pierre M. Bet, Journal of Clinical Pharmacy and Therapeutics	2022	12

Page 1